Femasys Inc (FEMY) — 10-Q Filings
All 10-Q filings from Femasys Inc. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Femasys Revenue Jumps 41% Amidst Expanding Global Approvals for FemBloc
— Nov 14, 2025 Risk: high
Femasys Inc. (FEMY) reported a net loss of $14,677,582 for the nine months ended September 30, 2025, an increase from a net loss of $13,692,944 in the prior yea -
Femasys Widens Losses Amid R&D Push, Revenue Declines 25%
— Aug 8, 2025 Risk: high
FEMASYS INC reported a net loss of $5.3 million for the three months ended June 30, 2025, a significant increase from the $4.1 million net loss in the prior-yea -
Femasys Inc. Files Q1 2025 10-Q Report
— May 8, 2025 Risk: low
Femasys Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware with its principal executive off -
FemSys Inc. Files Q3 2024 10-Q Report
— Nov 12, 2024 Risk: low
FemSys Inc. filed its 10-Q for the period ending September 30, 2024. The company, based in Suwanee, GA, operates in the Surgical & Medical Instruments & Apparat -
FemSys Inc. Files Q2 2024 10-Q Report
— Aug 8, 2024 Risk: medium
FemSys Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Specifi -
Femasys Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: low
FEMASYS INC (FEMY) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Femasys Inc. filed a 10-Q report for the period ending March 31, 2024. The filin
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX